,,iv #aaith ,,congress #ast ,session ,h4 ,,res4 #fhe ,,in ,,the ,,house ,,of ,,representatives ,september #i1 #bjbe,mrs4 ,cammack 7for herself1 ,ms4 ,kamlager-,dove1 ,mrs4 ,kim1 ,ms4 ,pettersen1 ,mrs4 ,hinson1 ,ms4 ,adams1 ,mrs4 ,cherfilus-,mc,cormick1 and ,mr4 ,landsman7 submitted the following resolution2 which was referred to the ,committee on ,energy and ,commerce ,,resolution ,expressing support for testing for antiphospholipid syndrome 7,,aps7 as a standard part of prenatal screening1 and for other purposes4 ,whereas antiphospholipid syndrome 7,,aps7 is a condition in which the immune system of an individual mistakenly produces antibodies that increase the risk of blood clots2 ,whereas ,,aps can increase the risk of miscarriages1 stillbirths1 and pregnancy complications2 ,whereas professional medical associations and guideline-setting bodies do not recommend testing for ,,aps as a standard part of prenatal screening2 ,whereas professional medical associations and guideline-setting bodies recommend testing for ,,aps only if a woman has an unexplained fetal loss after #aj weeks or #c or more unexplained embryonic losses 7miscarriages72 ,whereas ,,aps is responsible for about #ae percent of recurrent pregnancy losses2 ,whereas the total number of miscarriages caused by ,,aps is unknown because it is not tested as part of normal prenatal screening2 ,whereas ,,aps can be detected by a blood test and treated by blood thinners2 and ,whereas testing for ,,aps during normal prenatal screening can save babies and reduce grief for women and families3 ,now1 therefore1 be it ,that the ,house of ,representatives-- 7#a7 supports testing for antiphospholipid syndrome 7,,aps7 as a standard part of prenatal screening2 and 7#b7 calls upon professional medical associations and guideline-setting bodies to update their recommendations to include testing for ,,aps as a standard part of prenatal screening4